Screener
Amphastar Pharmaceuticals AMPH Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Finance lease right-of-use assets | 152 | 221 |
| Operating lease right-of-use assets | 72,911 | 42,931 |
| Goodwill and intangible assets, net | 647,833 | 565,965 |
| Other assets | 33,392 | 31,135 |
| Deferred tax assets | 42,464 | 42,464 |
| Total assets | $1,743,766 | $1,629,299 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's other non-current assets?
- Amphastar Pharmaceuticals (AMPH) reported other non-current assets of $33.39M in Q2 2026.
- How has Amphastar Pharmaceuticals's other non-current assets changed year-over-year?
- Amphastar Pharmaceuticals's other non-current assets increased by 18.8% year-over-year, from $28.1M to $33.39M.
- What is the long-term trend for Amphastar Pharmaceuticals's other non-current assets?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's other non-current assets has grown at a 42.8% compound annual growth rate (CAGR), from $5.25M to $31.14M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Amphastar Pharmaceuticals's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude